Capped mRNA Quantification by Enzymatic Fragmentation and Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective lipid nanoparticle compositions that can systematically deliver therapeutic agents, such as mRNA, to the lungs for the treatment of lung diseases, and methods to accurately quantify the amount of capped mRNA in mRNA samples.
Innovation Solution
Lipid nanoparticle compositions are developed to target the lungs, and a method is provided to quantify capped mRNA by using a combination of enzymes like nuclease, alkaline phosphatase, and polynucleotide kinase, followed by chromatographic separation and comparison with standard mRNA samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional quantification methods are used for capped mRNA, then the process is simpler, but the accuracy and reliability of quantification is insufficient
Solution Approach 1:
The quantification method is segmented into distinct enzymatic steps: nuclease treatment to generate 5' fragments, alkaline phosphatase treatment to remove phosphates, and polynucleotide kinase treatment to phosphorylate 5' ends. Each step targets a specific molecular feature, enabling progressive separation and quantification of capped versus uncapped mRNA through chromatographic analysis
Solution Approach 2:
Enzymes serve as intermediaries to transform mRNA molecules into distinguishable forms. The nuclease, alkaline phosphatase, and polynucleotide kinase act as mediators that modify mRNA in a sequence-dependent manner, creating detectable differences between capped and uncapped molecules that enable accurate quantification through standard chromatographic methods
2Productivity
If lipid nanoparticle compositions are developed for lung delivery, then therapeutic delivery efficiency is improved, but the complexity of formulation and delivery system increases
Solution Approach 1:
The lipid nanoparticle formulation utilizes parameter changes in lipid composition, including ionizable lipids with specific pKa values, helper lipids, and PEGylated lipids in optimized ratios. These parameter changes enable the nanoparticles to respond to physiological conditions (pH, ionic strength) for targeted lung delivery while maintaining controllable formulation complexity through systematic optimization
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves accurate quantification of capped mRNA, enhancing the delivery efficiency of therapeutic agents to the lungs for treating lung diseases.
Implementation Method 1
the mRNA in the sample is contacted with the nuclease under conditions sufficient to create 5′ end fragments of mRNA
Implementation Method 2
the mRNA in the sample is contacted with the alkaline phosphatase under conditions sufficient to remove a triphosphate group and/or a 3′ linear phosphate group from an mRNA molecule
Implementation Method 3
the mRNA in the sample is contacted with the polynucleotide kinase under conditions sufficient to remove a cyclic phosphate group from the 3′ end of an mRNA molecule
Implementation Method 4
separating the capped mRNA and the uncapped mRNA occurs using chromatography
Data Source
AI summary
Provided are a method for quantifying an amount of capped messenger RNA (mRNA) in an mRNA sample comprising contacting the mRNA with two or more of a nuclease, an alkaline phosphatase, and a polynucleotide kinase and separating the capped mRNA and the uncapped mRNA occurs using chromatography.